Interv Akut Kardiol. 2009;8(5):255-258

Peripartum cardiomyopathy - case report and concise review

Tomáš Belza1, Pavel Švancar2, Rostislav Polášek1, Dušan Morman
1 Kardiologické oddělení, Krajská nemocnice Liberec
2 ARO Krajská nemocnice Liberec

Peripartum cardiomyopathy (PPCM) is a rare, but life threatening disease, which affects women in the last month of pregnancy or in the

first five months after delivery (1). Our case report describes a case of patient, who was admitted for shortness of breath and rapidly

worsening shock closely after Caesarean section. The termination of pregnancy was indicated acutely for the signs of fetal hypoxia due to

accidentally detected incesant supraventricular tachycardia of the mother. As the cause of the shock was diagnosed heart failure due to

peripartum cardiomyopathy. The treatment was symptomatic by diuretics, inotropes, amiodarone, later on betablocker and ACEI. The mechanical

cardiac support was not required. The signs of heart failure subsided in two weeks, in subsequent period the left ventricular

ejection fraction turned normal as well. This positive state lasts during the two-year follow-up till now. There was a rehospitalisation for

fatique and faintness, caused by hyperthyreoidism, probably in consequens of transient administration of amiodarone, which indication

was incesant supraventricular tachycardia in the acute settings. There was no rehospitalisation for heart failure or arrhythmias. There is

a discussion of diagnostic, treatment and prognosis of peripartum cardiomyopathy in the article.

Keywords: peripartum cardiomyopathy, heart failure, cardiomyopathy, pregnancy.

Published: November 20, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Belza T, Švancar P, Polášek R, Morman D. Peripartum cardiomyopathy - case report and concise review. Interv Akut Kardiol. 2009;8(5):255-258.
Download citation

References

  1. Rose R, Skopic A, Hersh J. Peripartum Cardiomyopathy: A Case Report. Am J Clin Med 2004; 2: 20-25.
  2. Pérez-Silva A, Merino JL. Tachycardia-induced cardiomyopathy [online]. E-Journal 2009; 17(16) [cit. 22. srpna 2009]. Dostupné na www: http://www.escardio.org/communities/councils/ccp/e-journal/volume7/Pages/tachycardia-inducedcardiomyopathy.aspx.
  3. Demakis JG, Rahimtoola SH. Peripartum Cardiomyopathy. Circulation 1971; 44: 964-968. Go to original source... Go to PubMed...
  4. Pearson GD, Veille JC, Rahimtoola SH, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000; 283(9): 1183-1188. Go to original source... Go to PubMed...
  5. Anderson JE, Olsen EG, Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 1986;56: 285. Go to original source... Go to PubMed...
  6. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jakson G. Peripartum Cardiomyopathy due to myocarditis. NEJM 1982; 307: 731-734. Go to original source... Go to PubMed...
  7. Midei MG, DeMent SH, Feldman AM, Hutschins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990; 81: 922-928. Go to original source... Go to PubMed...
  8. Nelson JL. Pregnancy, persistent microchimerism, and autoimmune disease. J Am Med Womens Assoc 1998; 53: 31. Go to PubMed...
  9. Coulson CI, Thorp JMJ, Mayer DC, Cedilo RC. Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstetr and Gynecol 1996; 87: 610-612. Go to original source... Go to PubMed...
  10. Bhakta P, Biswas BK, Banerjee B. Peripartum cardiomyopathy: Review of the Literature Yonsei Med J 2007; 48(5): 731-747. Go to original source... Go to PubMed...
  11. McNamara DM. Treatment of Peripartum Cardiomyopathy [online]. 2nd Virtual Congress of Cardiology, September 1st - November 30th 2001 [cit. 20. června 2009]. Dostupné na www: http://www.fac.org.ar/scvc/llave/cardio-l/namara/namarai.htm.
  12. Benlolo S, Lefoll C, et al. Successful Use of Levosimendan in a Patient with Peripartum Cardiomyopathy. Anesth Analg 2004; 98: 822-824. Go to original source... Go to PubMed...
  13. Nguyen HD, et al. Levosimendan for Post-partum Cardiomyopathy. Crit Care Resus 2005; 7: 107-110.
  14. Clark S, Cotton D, Lee W. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol. 1989; 169: 1439-1442. Go to original source... Go to PubMed...
  15. Nabhan A. Peripartum Cardiomyopathy. Ain Shaim J Obstet Gyn [online]. March 2005; 2 [cit. 20. června 2009]. Dostupné na www: http://www.asjog.org/journal/V2Issue1/231%20Reviews%20-Peripartum%20cardiomyopathy_A.Nabhanstg4-iss4.pdf.
  16. Ramajan R, Sorrel VL. Peripartum cardiomyopathy: Cause, diagnosis, and treatment. Clev Clin J Med 2009; 76(5): 289-296. Go to original source... Go to PubMed...
  17. Widimský J jr., Cífková R, Špinar J, et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007, Doporučení České společnosti pro hypertenzi. Cor Vasa 2008; 50(1): Kardio.
  18. Sliwa K, Skudicky D, et al. The addition of pentoxifylline to conventional therapy improves outcome in patiens with peripartum cardiomyopathy. Eur J Heart Fail 2002; 4: 305-309. Go to original source... Go to PubMed...
  19. Ibebuogu UN, Thornton JW, Reed GL. An unusual case of peripartum cardiomyopathy manifesting with multiple trombo-embolic phenomena. Thrombosis J [online] 2007; 5 [cit. 20. června 2009]. Dostupné na www: http://www.thrombosisjournal.com/content/5/1/18. Go to original source... Go to PubMed...
  20. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood [online] 2005; 106: 401-407 [cit. 20. června 2009]. Dostupné na www: http://bloodjournal.hematologylibrary.org/cgi/reprint/106/2/401. Go to original source... Go to PubMed...
  21. Baughman KL. Management of a case of peripartum cardiomyopathy. Nature Clin Prac Card Med 2006; 3(9): 514-518. Go to original source... Go to PubMed...
  22. Keogh A, Macdonald P, Spratt P, et al. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant 1994; 13: 202.
  23. Ardehali H, Kasper EK, Baughman KL. Peripartum cardiomyopathy Minerva Cardioangiologica [online] 2003; 51(1): 41-48 [cit. 20. června 2009]. Dostupné na www: http://cat.inist.fr.
  24. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050-2055. Go to original source... Go to PubMed...
  25. Duran N, Gunes H, Duran I, Biteker M, Ozkan M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 2008; 101: 137-140. Go to original source... Go to PubMed...
  26. Baughman KL. Management of a case of peripartum cardiomyopathy. Nature Clin Prac Card Med 2006; 3(9): 514-518. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.